Hepcidin抗体;Hepcidin Antibody—艾普蒂 新品

+ +

•  

   

     Western blot analysis of Hepcidin expression in Human Hepcidin Full-length Recombinant Protein (GFP Tagged).    

  
  

Hepcidin, a 25-amino acid peptide hormone predominantly synthesized in the liver, plays a central role in regulating systemic iron homeostasis. Discovered in 2001. it acts by binding to the iron exporter ferroportin on enterocytes and macrophages, triggering its internalization and degradation. This process reduces dietary iron absorption and inhibits iron recycling from stored sources, making hepcidin a critical mediator of iron availability. Dysregulated hepcidin expression is implicated in various disorders: elevated levels contribute to anemia of chronic disease by trapping iron in macrophages, while deficiencies lead to iron overload conditions like hereditary hemochromatosis.

Hepcidin antibodies, both monoclonal and polyclonal, are essential tools for quantifying hepcidin levels in research and clinical settings. Immunoassays (e.g., ELISA) and Western blotting rely on these antibodies to diagnose iron metabolism disorders and monitor disease progression. Therapeutically, anti-hepcidin antibodies are under investigation for treating iron-related pathologies. Neutralizing antibodies may alleviate anemia in chronic inflammation by restoring iron mobilization, whereas agonist antibodies could mitigate iron overload. Challenges remain in optimizing antibody specificity due to hepcidin's small size and structural homology with other peptides. Nonetheless, advancing antibody-based strategies holds promise for precision therapies targeting iron dysregulation, bridging gaps in managing conditions from anemia to neurodegenerative diseases linked to iron imbalance.